Evaluating Random-Access CLIA for Anti-TNF Drug Monitoring: a Comparison with Traditional ELISA

Key Points

• This research aims to assess the reliability and efficiency of the i-TRACK10 CLIA analyzer for anti-TNF drug monitoring compared to ELISA.
• Evaluation of i-TRACK10 analyzer using anti-TNF agents.
• Comparison with traditional ELISA kits.
• Assessment of accuracy and efficiency in drug monitoring.
• The i-TRACK10 analyzer demonstrated higher accuracy compared to conventional ELISA.
• Enhanced automation reduced processing time significantly.
• Integration into clinical workflows is supported by improved performance characteristics.

Abstract